Ligne de temps
Etienne Simon-Loriere
Responsable de Structure
10 avr. 2024
13 mars 2024
publication
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion.
Lire plus13 déc. 2023
01 nov. 2023
publication
Untargeted metagenomic sequencing identifies Toscana virus in patients with idiopathic meningitis, southern Spain, 2015 to 2019.
Lire plus25 oct. 2023
26 juil. 2023
publication
Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants.
Lire plus24 mai 2023
publication
APOBEC3F is a mutational driver of the human Monkeypox virus identified in the 2022 outbreak.
Lire plus21 avr. 2023
publication
Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages.
Lire plus14 févr. 2023
publication
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies.
Lire plus03 févr. 2023
publication
Tocilizumab treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants.
Lire plus13 déc. 2022
event
PICREID Midterm Meeting Keynote Speaker Event: Novel discoveries in emerging infectious diseases (Kei Sato, Keita Matsuno and Akatsuki Saito)
Lire plus24 nov. 2022
event
PICREID project Midterm Meeting: Pasteur International Center for Research on Emerging Infectious Diseases
Lire plus17 nov. 2022
publication
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies.
Lire plus05 oct. 2022
publication
Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection.
Lire plus04 juil. 2022
publication
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
Lire plus17 juin 2022
news
New publication – Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2
Lire plus01 juin 2022
publication
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies.
Lire plus04 mai 2022
publication
Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen.
Lire plus01 avr. 2022
12 mars 2022
publication
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2.
Lire plus01 févr. 2022
09 nov. 2021
01 nov. 2021
publication
A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters
Lire plus29 sept. 2021
08 juil. 2021
24 juin 2021
11 juin 2021
news
COVID-19: sensitivity of the Indian variant (B.1.617.2) to monoclonal antibodies and sera from convalescent and vaccinated individuals
Lire plus10 févr. 2021
publication
Recent African strains of Zika virus display higher transmissibility and fetal pathogenicity than Asian strains.
Lire plus09 oct. 2020
03 sept. 2020
03 août 2020
01 juil. 2020
publication
Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020.
Lire plus17 janv. 2020
publication
Genetic Diversity of Collaborative Cross Mice Controls Viral Replication, Clinical Severity, and Brain Pathology Induced by Zika Virus Infection, Independently of Oas1b.
Lire plus21 juin 2019
publication
A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice
Lire plus18 juin 2019
06 févr. 2019
project
MICROTONE – Microbial and viral circulations among people and wild and domesticated animals in an ecotone, Democratic Republic of Congo
Lire plus08 oct. 2018
patent
A Zika virus chimeric polyepitope comprising non-structural proteins and its use in immunogenic composition (EP 17 306553.3)
Lire plus10 juil. 2018
01 avr. 2018
15 févr. 2018
publication
Joint ancestry and association test indicate two distinct pathogenic pathways involved in classical dengue fever and dengue shock syndrome
Lire plus19 janv. 2018
05 sept. 2017
30 août 2017
publication
Increased adaptive immune responses and proper feedback regulation protect against clinical dengue.
Lire plus14 juin 2017
publication
Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells.
Lire plus13 avr. 2017
12 avr. 2017
03 nov. 2016
01 nov. 2016
publication
Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses.
Lire plus27 oct. 2016
publication
ZIKA virus elicits P53 activation and genotoxic stress in human neural progenitors similar to mutations involved in severe forms of genetic microcephaly and p53
Lire plus10 août 2016
publication
Interferon-Induced Spermidine-Spermine Acetyltransferase and Polyamine Depletion Restrict Zika and Chikungunya Viruses.
Lire plus24 juin 2015
publication
Distinct lineages of Ebola virus in Guinea during the 2014 West African epidemic
Lire plus10 juin 2015
publication
High Anti-Dengue Virus Activity of the OAS Gene Family Is Associated With Increased Severity of Dengue
Lire plus11 mai 2015
24 oct. 2013
publication
Genetic diversity of the highly variable V1 region interferes with Human Immunodeficiency Virus type 1 envelope functionality
Lire plus17 mai 2013
13 mars 2013
publication
Gene duplication is infrequent in the recent evolutionary history of RNA viruses
Lire plus23 août 2012
publication
Retrovolution: HIV-driven evolution of cellular genes and improvement of anticancer drug activation
Lire plus15 févr. 2012
publication
Level of gene expression is a major determinant of protein evolution in the viral order Mononegavirales
Lire plus04 juil. 2011
01 mars 2011
29 sept. 2010
08 mai 2009
publication
Molecular mechanisms of recombination restriction in the envelope gene of the human immunodeficiency virus
Lire plus12 sept. 2008
04 mars 2008
26 sept. 2006
publication